Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   RAC December 16, 2004 - Presentation Materials 98th Meeting Bethesda, Maryland Call to Order and Opening Remarks     Diane Wara, M.D., Chair, NIH RAC     Webcast     Minutes of the September 23, 2004, RAC Meeting     RAC Reviewers: Martha Bohn, Ph.D. Stephen Dewhurst, Ph.D.     Webcast     Discussion of Human Gene Transfer Protocol #0410-679     Phase I Clinical Trial of rAAV2.5-CMV-Minidystrophin Gene Vector in Duchenne Muscular Dystrophy     Jerry Mendell, M.D. Columbus Children's Research Institute, Columbus, OH     Webcast     DVD Video on Duchenne Muscular Dystrophy     Webcast     Data Management Report     Webcast     Followup on Safety Symposium: Safety Considerations in Recombinant DNA Research with Pathogenic Viruses—Development of a Web-Based Resource     Marina O'Reilly, Ph.D., Office of Biotechnology Activities     Webcast Slides     The Immune Response to Lymphopenia     Crystal MacKall, M.D., National Cancer Institute, Bethesda, MD     Webcast Slides     Discussion of Human Gene Transfer Protocol #0410-675     Development of Effective Immunotherapy for Prostate Cancer Patients: Phase I/II Study of Human GM-CSF Gene-Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX�) in Advanced Prostate Cancer Patients Made Lymphopenic by Chemotherapy and Infused with Autologous Peripheral Blood Mononuclear Cells     Walter Urba, M.D., Ph.D. Earle A. Chiles Research Institute, Portland, OR     Webcast Slides     ADJOURN     Top of Page     6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov RDNA309